文献速递基础与转化研究新药、器械与细胞基因治疗研发

荜茇明碱减轻氨基糖苷类诱导的TRPV1活性并保护小鼠听力损失

Piplartine attenuates aminoglycoside-induced TRPV1 activity and protects from hearing loss in mice.
PubMed 文献 · Sci Transl Med · 2024-08-07

研究以斑马鱼为发现平台筛选生物活性化合物,并对荜茇明碱(piplartine)的理化与治疗特性进行表征。荜茇明碱治疗窗宽,在斑马鱼体内不引起肾毒性且不干扰氨基糖苷类抗菌活性,在卡那霉素耳毒性小鼠模型中保护听力功能、外毛细胞和突触前带。机制上,荜茇明碱使卡那霉素诱导的TRPV1表达上调恢复正常并调节该受体的门控特性。

要点

  • 荜茇明碱在斑马鱼体内不引起肾毒性,也不干扰氨基糖苷类的抗菌活性
  • 在卡那霉素耳毒性小鼠模型中,荜茇明碱保护听力功能、外毛细胞和突触前带
  • 荜茇明碱使卡那霉素诱导的TRPV1表达上调恢复正常,并调节TRPV1门控特性

核心结论

  • 荜茇明碱具有较宽的治疗窗,在斑马鱼和卡那霉素耳毒性小鼠模型中保护听力,机制可能为通过调节TRPV1表达阻断氨基糖苷类进入内耳。

研究设计与样本

  • 研究以斑马鱼为发现平台进行生物活性化合物高通量筛选,并在斑马鱼与卡那霉素耳毒性小鼠模型中评价荜茇明碱;机制研究采用磷酸化组学、免疫印迹、免疫组化和分子动力学实验。

主要发现

  • 氨基糖苷类治疗可使40%至60%的接受治疗患者发生永久性听力损失,而美国食品药品监督管理局尚未批准任何预防或治疗此类听力损失的药物。
  • 荜茇明碱治疗窗宽,在斑马鱼体内不引起肾毒性,也不干扰氨基糖苷类的抗菌活性;基于荧光的测定显示荜茇明碱不抑制微粒体细胞色素C活性。
  • 在斑马鱼中,荜茇明碱与卡那霉素共同给药可保护免受卡那霉素诱导的毛细胞丢失;在小鼠卡那霉素耳毒性模型中,荜茇明碱保护听力功能、外毛细胞和突触前带。
  • 磷酸化组学、免疫印迹、免疫组化和分子动力学实验显示,荜茇明碱共同处理的小鼠耳蜗中AKT1信号上调。
  • 荜茇明碱使卡那霉素诱导的TRPV1表达上调恢复正常,并调节该受体的门控特性;因氨基糖苷类进入内耳部分由TRPV1介导,结果提示荜茇明碱通过调节TRPV1表达阻断氨基糖苷类进入。

关键数值与推荐

  • 氨基糖苷类治疗可导致40%至60%的接受治疗患者发生永久性听力损失。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hearing loss is a major health concern in our society, affecting more than 400 million people worldwide. Among the causes, aminoglycoside therapy can result in permanent hearing loss in 40% to 60% of patients receiving treatment, and despite these high numbers, no drug for preventing or treating this type of hearing loss has yet been approved by the US Food and Drug Administration. We have previously conducted high-throughput screenings of bioactive compounds, using zebrafish as our discovery platform, and identified piplartine as a potential therapeutic molecule. In the present study, we expanded this work and characterized piplartine's physicochemical and therapeutic properties. We showed that piplartine had a wide therapeutic window and neither induced nephrotoxicity in vivo in zebrafish nor interfered with aminoglycoside antibacterial activity. In addition, a fluorescence-based assay demonstrated that piplartine did not inhibit cytochrome C activity in microsomes. Coadministration of piplartine protected from kanamycin-induced hair cell loss in zebrafish and protected hearing function, outer hair cells, and presynaptic ribbons in a mouse model of kanamycin ototoxicity. Last, we investigated piplartine's mechanism of action by phospho-omics, immunoblotting, immunohistochemistry, and molecular dynamics experiments. We found an up-regulation of AKT1 signaling in the cochleas of mice cotreated with piplartine. Piplartine treatment normalized kanamycin-induced up-regulation of TRPV1 expression and modulated the gating properties of this receptor. Because aminoglycoside entrance to the inner ear is, in part, mediated by TRPV1, these results suggested that by regulating TRPV1 expression, piplartine blocked aminoglycoside's entrance, thereby preventing the long-term deleterious effects of aminoglycoside accumulation in the inner ear compartment.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Zallocchi M, Vijayakumar S, Fleegel J, et al. Piplartine attenuates aminoglycoside-induced TRPV1 activity and protects from hearing loss in mice. Sci Transl Med. 2024. PMID: 39110778. doi:10.1126/scitranslmed.adn2140

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。